DISCUSSION
AD is a chronic relapsing skin disease of complex etiology,
characterized by an erythematous and pruritic rash that often affects
children.AD prevalence is between 5 and 20% (4).AD is usually
associated with a high serum total IgE level and a personal or family
history of atopy that includes a group of diseases such as eczema,
asthma, and allergic rhinitis. EH, also known as Kaposi’s varicelliform
eruption, is a rare complication that occurs in less than 3% of
patients with atopic dermatitis. The most common causes of EH are herpes
simplex virus (HSV) type 1 and type 2.it has also been shown that
coxsackie virus A16 and vaccinia virus play a role in the pathogenesis
of EH (5).EH may spread to disseminated or fatal course with visceral
involvement in some patients.The mortality rate is between 1 and 9%
(6).Severe eczema, high serum total IgE levels, a history of food
allergy or asthma appear to be predisposing factors (7).Although the
disease can be seen clinically wherever there is epithelial barrier
damage in the body, it is most commonly located in the face and neck
region. The presence of common worms with a diameter of 2-3 mm is a clue
for diagnosis.Fever and regional lymphadenopathies may accompany the
lesions (8).Similar to the literature, common worms on the face were
observed in our patient, but no fever or lymphadenopathy was
observed.Electron microscopy, viral culture and PCR can be used for
diagnosis.In the differential diagnosis, allergic contact dermatitis,
impetigo and histiocytosis, especially varicella zoster, should be
considered(9).In the treatment of EH, systemic antiviral and
antibacterial therapy should be planned in addition to topical antiviral
and antibacterial therapy, depending on the extent of the lesion (10).In
our patient, oral amoxicillin + clavulanic acid and acyclovir and
topical acyclovir treatment were given due to the widespread involvement
in the face area. The lesions were completely controlled within a
month.There is no data in the literature on EH after AIT.Since there is
no data on eczema herpeticum after AIT in the literature, we wanted to
share a very rare case.
REFERANCES
1. Noon L. Prophylactic inoculation against hay fever. Lancet
1911;1:1572-3.
2.. Freeman J. Further observations on the treatment of hay fever by
hypodermic inoculations of pollen vaccine. Lancet 1911;2:814- 7
3.Damour A, Garcia M, Seneschal J, Lévêque N, Bodet C. Eczema
Herpeticum: Clinical and Pathophysiological Aspects. Clin Rev Allergy
Immunol. 2020 Aug;59(1):1-18. doi: 10.1007/s12016-019-08768-3. PMID:
31836943.
4.SpergelJM.From atopic dermatitis to asthma:the atopic march .Ann
Allergy Asthma Immunol 2010; 105:99.
5.12.Mackley CL, Adams DR, Anderson B, Miller JJ. Eczema herpeticum: a
dermatologic emergency. Dermatol Nurs 2002;14(5):307-10
6.11.Olson J, Robles DT, Kirby P, Colven R. Kaposi varicelli- form
eruption (eczema herpeticum). Dermatol Online J 2008;14(2):18.
7.LeungDY.Why is eczema herpeticum unexpectedly rare?
AntiviralRes2013;98:153.
8.Peng WM, Jenneck C, Bussmann C, et al. Risk factors of atopic
dermatitis patients for eczema herpeticum. J Invest Dermatol
2007;127(5):1261-3.
9.Şenel E.Eczema Herpeticum: A case report. Dicle medical journal.2011;
38 (3): 342-344
10.Kimata H. Rapidly increasing incidence of Kaposi’s varicel- liform
eruption in patients with atopic dermatitis. Indian J Dermatol Venereol
Leprol 2008;74(3):260-1